An intervention targeting service providers and clients for methadone maintenance treatment in China: A cluster-randomized trial

Addiction

Volumn 108, Issue 2, 2013, Pages 356-366

  Li, Li ^a   Wu, Zunyou ^b   Liang, Li Jung ^a   Lin, Chunqing ^a   Zhang, Linglin ^c   Guo, Sam ^a   Rou, Keming ^b   Li, Jianhua ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c Sichuan Provincial Center for Disease Control and Prevention   (China)

^d Yunnan Institute on Drug Abuse   (China)

Author keywords

China; Drug use; Intervention pilot; Methadone maintenance therapy; Motivational interviewing; Providers

Indexed keywords

METHADONE;

ADULT; ATTITUDE TO HEALTH; CHINA; CLINICAL TRIAL; CLUSTER ANALYSIS; CONTROLLED STUDY; DRUG DEPENDENCE TREATMENT; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; OUTPATIENT DEPARTMENT; PILOT STUDY; PROGRAM EVALUATION; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; STANDARDS;

ADULT; AMBULATORY CARE FACILITIES; CHINA; CLUSTER ANALYSIS; FEMALE; FOLLOW-UP STUDIES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; METHADONE; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PILOT PROJECTS; PROGRAM EVALUATION; QUESTIONNAIRES; SUBSTANCE ABUSE TREATMENT CENTERS;

EID: 84872608526     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2012.04020.x     Document Type: Article

References (38)

1. Wu Z. Y., Sullivan S. G., Wang Y., Rotheram-Borus M. J., Detels R. Evolution of China's response to HIV/AIDS. Lancet 2007; 369: 679-690.
2. China Ministry of Health, Joint United Nations Programme on HIV/AIDS, World Health Organization. 2011 Estimates for the HIV/AIDS Epidemic in China. 2007. Available at: http://news.sciencenet.cn/upload/news/file/2012/1/20121291555312820.pdf (accessed 13 February 2012; archived by Webcite at http://www.webcitation.org/69mT95NAd).
3. Pang L., Hao Y., Mi G. D., Wang C. H., Luo W., Rou K. M. etal. Effectiveness of first eight methadone maintenance treatment clinics in China. AIDS 2007; 21: S103-107.
4. Sullivan G. S., Wu Z. Rapid scale up of harm reduction in China. Int J Drug Policy 2007; 18: 118-128.
5. Cao X. B., Pang L., Rou K. M., Yin W. Y., Wang C. H., Luo W. etal. Five-year follow-up study of the retention rate and its risk factors for the first 1057 methadone maintenance treatment patients in China. Chin J AIDS STD 2010; 16: 211-214.
6. Li L., Wu Z. Y., Cao X. B., Zhang L. L. Provider-client interaction in methadone treatment clinics in China. J Drug Issues 2012; 42: 147-55.
7. Lin C., Wu Z. Y., Rou K. M., Yin W. Y., Wang C. H., Shoptaw S. etal. Structural-level factors affecting implementation of the methadone maintenance therapy program in China. J Subst Abuse Treat 2010; 38: 119-127.
8. Liu E. W., Liang T., Shen L. M., Wang B., Wu Z., Detels R. Correlates of methadone client retention: a prospective cohort study in Guizhou province, China. Int J Drug Policy 2009; 20: 304-308.
9. Yin W. Y., Hao Y., Sun X. H., Li F., Li J. H., Rou K. M. etal. Scaling up the national methadone maintenance treatment program in China: achievements and challenges. Int J Epidemiol 2010; 39: ii29-37.
10. Darker C. D., Sweeney B. P., El Hassan H. O., Smyth B. P., Ivers J. H., Barry J. M. Brief interventions are effective in reducing alcohol consumption in opiate-dependent methadone-maintained patients: results from an implementation study. Drug Alcohol Rev 2012; 31: 348-356.
11. DeFulio A., Silverman K. Employment-based abstinence reinforcement as a maintenance intervention for the treatment of cocaine dependence: post-intervention outcomes. Addiction 2011; 106: 960-967.
12. Nyamathi A. M., Nandy K., Greengold B., Marfisee M., Khalilifard F., Cohen A. etal. Effectiveness of intervention on improvement of drug use among methadone maintained adults. J Addict Dis 2011; 30: 6-16.
13. Heritage J., Maynard D. W. Problems and prospects in the study of physician-patient interaction: 30 years of research. Annu Rev Sociol 2006; 32: 351-374.
14. Jackson T. R. Treatment practice and research issues in improving opioid treatment outcomes. Sci Pract Perspect 2002; 1: 22-28.
15. Matthias M. S., Parpart A. L., Nyland K. A., Huffman M. A., Stubbs D. L., Sargent C. etal. The patient-provider relationship in chronic pain care: providers' perspectives. Pain Med 2010; 11: 1688-1697.
16. Neumann M., Edelhäuser F., Kreps G. L., Scheffer C., Lutz G., Tauschel D. etal. Can patient-provider interaction increase the effectiveness of medical treatment or even substitute it?-an exploration on why and how to study the specific effect of the provider. Patient Educ Couns 2010; 80: 307-314.
17. Lin C., Wu Z. Y., Rou K. M., Pang L., Cao X. B., Shoptaw S. etal. Challenges in providing service in methadone maintenance therapy clinics in China: service providers' perceptions. Int J Drug Policy 2010; 21: 173-178.
18. Han L., Ling L., Xia Y., Chen W., Chen A., Chen J. etal. Status quo and policy recommendations of methadone maintenance treatment clinics in Guangdong Province. Chin J Health Policy 2010; 3: 34-38.
19. Lin C., Detels R. A qualitative study exploring the reason for low dosage of methadone prescribed in the MMT clinics in China. Drug Alcohol Depend 2011; 117: 45-49.
20. Chawarski M. C., Zhou W., Schottenfeld R. S. Behavioral drug and HIV risk reduction counseling (BDRC) in MMT programs in Wuhan, China: a pilot randomized clinical trial. Drug Alcohol Depend 2011; 115: 237-239.
21. Hser Y. I., Li J., Jiang H., Zhang R., Du J., Zhang C. etal. Effects of a randomized contingency management intervention on opiate abstinence and retention in methadone maintenance treatment in China. Addiction 2011; 106: 1801-1809.
22. Yang Y. C., Duan S., Xiang L. F., Ye R. H., Gao J., Yang S. S. etal. Adherence and related determinants on methadone maintenance treatment among heroin addicts in Dehong prefecture, Yunnan province. Zhonghua Liu Xing Bing Xue Za Zhi 2011; 32: 125-129.
23. Ministry of Health, China, Joint United Nations Programme on HIV/AIDS, World Health Organization. 2009 Estimates for the HIV/AIDS Epidemic in China. 2010. Available at: http://aidsdatahub.org/en/china-reference-library/item/5267-2009-estimates-for-the-hiv/aids-epidemic-in-china-ministry-of-health-china-unaids-and-who-2010 (accessed 13 February 2012; archived by Webcite at http://www.webcitation.org/69mTPq7pa).
24. Bao Y. P., Liu Z. M. Systematic review of HIV and HCV infection among drug users in China. Int J STD AIDS 2009; 20: 399-405.
25. Caplehorn J., Irwig L., Saunders J. B. Attitudes and beliefs of staff working in methadone maintenance clinics. Subst Use Misuse 1996; 31: 437-452.
26. National MMT working group. Methadone Maintenance Therapy clinical guidance handbook. 2005. Available at: http://www.chinaaids.cn/chinammt/download/support/guide2006.pdf (accessed 13 February 2012; archived by Webcite at http://www.webcitation.org/69mTiJuwH).
27. Li L., Lin C., Wu Z. Y., Wu S., Rotheram-Borus M. J., Detels R. etal. Stigmatization and shame: consequences of caring for HIV/AIDS patients in China. AIDS Care 2007; 19: 258-263.
28. Li L., Liang L. J., Wu Z. Y., Lin C., Wu S. Institutional support for HIV/AIDS care in China: a multilevel analysis. AIDS Care 2008; 20: 1190-1196.
29. Martin G. W., Wilkinson D. A., Poulos C. X. The drug avoidance self-efficacy scale. J Subst Abuse 1995; 7: 151-163.
30. Ciesla J. R., Spear S. F. Concordance of self-reported drug use and qualitative urinalysis in adolescents treated for substance abuse. Clin Drug Investig 2001; 21: 789-795.
31. McLellan A. T., Kushner H., Metzger D., Peters R., Smith I., Grissom G. etal. The fifth edition of the addiction severity index. J Subst Abuse Treat 1992; 9: 199-213.
32. Deering D. E., Sheridan J., Sellman J. D., Adamson S. J., Pooley S., Robertson R. etal. Consumer and treatment provider perspectives on reducing barriers to opioid substitution treatment and improving treatment attractiveness. Addict Behav 2011; 36: 636-642.
33. Strathdee S. A., Hallett T. B., Bobrova N., Rhodes T., Booth R., Abdool R. etal. HIV and risk environment for injecting drug users: the past, present and future. Lancet 2010; 376: 268-284.
34. Burke B. L., Arkowitz H., Menchola M. The efficacy of motivational interviewing: a meta-analysis of controlled clinical trials. J Consult Clin Psychol 2003; 71: 843-861.
35. Joe G. W., Simpon D. D., Dansereau D. F., Rowan-Szal G. A. Relationships between counseling rapport and drug abuse treatment outcomes. Psychiatr Serv 2001; 52: 1223-1229.
36. Magura S., Nwakeze P. C., Kang S. Y., Demsky S. Program quality effects on patient outcomes during methadone maintenace: a study of 17 clinics. Subst Use Misuse 1999; 34: 1299-1324.
37. Simpson D. D., Joe G. W., Rowan-Szal G. A., Greener J. M. Drug abuse treatment process components that improve retention. J Subst Abuse Treat 1997; 14: 565-572.
38. Blaney T., Craig R. J. Methadone maintenance. Does dose determine differences in outcome? J Subst Abuse Treat 1999; 16: 221-228.